AveXis Inc (AVXS)

NASDAQ
217.83
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    217.71 - 217.94
  • 52 wk Range:
    0.00 - 0.00

AVXS Overview

Prev. Close
217.65
Day's Range
217.71-217.94
Revenue
-
Open
217.78
52 wk Range
0-0
EPS
-12.34
Volume
0
Market Cap
8.02B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
501,327
P/E Ratio
-
Beta
-
1-Year Change
0%
Shares Outstanding
36,816,476
Next Earnings Date
-
What is your sentiment on AveXis?
or
Market is currently closed. Voting is open during market hours.

AveXis Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AveXis Inc Company Profile

AveXis Inc Company Profile

Employees
219

Novartis Gene Therapies, Inc., a gene therapy biotech company, develops treatments for rare and life-threatening genetic diseases. The company focuses on developing gene therapy product candidates for the treatment of type 1 spinal muscular atrophy, an autosomal-recessive genetic disorder characterized by lower motor neuron loss and progressive muscle weakness. It offers AVXS-101, a AveXis’ gene therapy for the treatment of spinal muscular atrophy SMA Type 1, which is in Phase 1 clinical trial. Novartis Gene Therapies, Inc. was formerly known as AveXis, Inc., and changed its name in September 2020. The company was founded in 2010 and is based in Bannockburn, Illinois. AveXis, Inc. operates as a subsidiary of Novartis AG.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy